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ABSTRACT. Background: Amino acids are an integral part of
parenteral nutrition because of their anabolic action helping to
conserve body protein after surgical stress. At the gastrointesti-
nal tract, an adequate supply of amino acids may be particularly
important because of the gut’s high rate of protein turnover, cell
division, and proliferation. However, no information is available
about the effects of amino acids on human intestinal protein
metabolism after surgery. Methods: Studies were performed in
postabsorptive patients 8–10 days after major abdominal surgery.
Mass spectrometry techniques (capillary gas chromatography/
combustion isotope ratio mass spectrometry) were used to
directly determine the incorporation rate of 1-[13C]-leucine into
colon mucosal protein. All subjects had a colostomy, which
allowed easy access to the colon mucosa, and consecutive sam-
pling from the same tissue was performed during continuous
isotope infusion (0.16 mol/kg min). Isotopic enrichments were
determined at baseline and after a 4-hour infusion of amino acids
or after infusion of saline (control group). Results: Compared with
baseline, infusion of amino acids reduced fractional colon protein
synthesis significantly by 29.2  8.3%. This decrease was also
significantly different from the corresponding (insignificant)
change during saline infusion (19.4  26.9%, p  .05 vs amino
acid group). Conclusions: After surgery, an amino acid infusion
acutely reduces postoperative colon protein synthesis. This effect
possibly may be attributed to interactions of specific amino acids
(glutamine) with an altered intestinal immune system and entero-
cyte activity. ( Journal of Parenteral and Enteral Nutrition
29:255–261, 2005)
Amino acid supply has gained its firm place during
parenteral nutrition in a wide range of patients who
cannot tolerate enteral feeding. Amino acids are usu-
ally considered necessary to reduce protein loss after
surgical stress. An optimal conservation of body pro-
tein will be obtained with daily administration of 1.2–
1.5 g amino acids per kg body weight.1 Potential ana-
bolic actions of amino acids are known to occur in
muscle and in splanchnic tissues.2 At the intestinal
tract, amino acid metabolism and protein turnover are
particularly important because an efficient formation
of new protein is essential for maintaining a high rate
of cell division and proliferation and for the pro-
duction of cellular structure compounds and secreted
enzymes.3,4 Unfortunately, in humans effects of spe-
cific substrates have almost exclusively been studied in
the whole splanchnic bed, not allowing a differentia-
tion between hepatic and intestinal changes.5–7 Virtu-
ally nothing is known on the effects of amino acids on
human intestinal protein metabolism in situ.
We sought in the present study to examine the
effects of a standard amino acid infusion on colon pro-
tein synthesis using stable isotopes (1-[13C]-leucine)
and advanced mass spectrometry techniques. Studies
were performed in patients after major abdominal sur-
gery whose mucosal function may be altered and who
are frequent candidates for parenteral nutrition.
MATERIALS AND METHODS
Subjects
Two groups of postoperative patients (control, n  5;
amino acid infusion, n  12) with cured rectal carci-
noma and colostomies were carefully screened through
their medical history, physical examinations, and rou-
tine blood tests. The groups were comparable with
respect to age (control, 64.8  3.9 years; amino acid
infusion, 63.5  2.9) and body mass index (control,
24.9  1.0 kg/cm2; amino acid infusion, 27.5  1.3).
Patients had had limited colorectal cancer and had
undergone curative, elective abdominal surgery, which
had also included construction of a colostomy. All
patients had a preoperative bowel preparation (ortho-
grade flushing by oral colonoscopy fluids) and received
prophylactic IV antibiotics at the time of surgery.
Anesthesia consisted of epidural application of analge-
sic and anesthetic drugs and was continued no longer
than the fifth postoperative day. The patients were
studied between days 8 and 10 after surgery, when
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body protein loss peaks,8 had an uneventful postoper-
ative course, and were free from signs of organ mal-
function and local or systemic infection. No patient
(before surgery) had a history of previous weight loss or
clinical and laboratory signs of malnutrition or meta-
bolic diseases. Informed consent was obtained after the
experimental protocol had been explained in detail.
The study was approved by the local institutional
review board (protocol 134/97).
Experimental Protocol
All subjects were inpatients of the general surgical
service. Before the study, patients received a mixed
diet (approximately 25 kcal/kg day, of which 5 kcal/kg
day were administered as protein or IV amino acids);
two-thirds of the calories were administered enterally
(liquids) and the other one-third parenterally. Of the
calculated energy demand (25 kcal/kg day), only 60%
was provided on day 1 to day 3 after surgery, 80%
between day 4 and day 6, and 100% thereafter. In any
case, a daily postoperative protein/amino acid intake of
1.2 g /kg was assured. Remaining nonprotein calories
were given as carbohydrates between day 1 and day 6.
After the sixth postoperative day, half of the nonpro-
tein calories were given as carbohydrates, the other
half as fat. Nutrition was started as parenteral nutri-
tion. If gastrointestinal function was considered suffi-
cient, tea per mouth was provided on postoperative
days 1 and 2, clear liquids on postoperative days 3 and
4, and regular liquid food on the subsequent days.
Daily oral consumption was recorded by the dieticians,
and eventual caloric deficits were compensated by
adjusting parenteral nutrition.
After 10 PM on the day before surgery, subjects
remained postabsorptive, except for consumption of
mineral water. A primed-constant infusion of 1-[13C]-
leucine (Tracer Technologies, Sommerville, MA; 99.3
atom percent enrichment) was started at 7 AM the next
day. The isotope infusion rate was 0.16 mol/kg min
(prime 9.6 mol/kg). A blood sample was collected
before isotope infusion to determine the background
enrichment of protein-bound and free plasma leucine.
Plasma background enrichments were used as an indi-
cator of intracellular protein-bound and free leucine
background enrichments.9
The first mucosa biopsy was performed after 180
minutes of isotope infusion, the second after 360 min-
utes, and the third after 600 minutes. The baseline
period (period I) ranged from minutes 180–360.
Between minutes 360 and 600 (after the second biopsy,
period II), patients in the amino acid group (n  12)
received a continuous infusion of commercial amino
acid solutions with comparable amino acid composition
(Glamin, Baxter, Erlangen, Germany; or Parenta-
min/Dipeptamin, Serag-Wiessner, Naila, Germany;
and Fresenius-Kabi, Bad Homburg, Germany). The
total amino acid infusion rate was 67 mg/kg h. Patients
in the control group remained in a fasting state (saline
infusion, n  5). Arterialized blood samples for mea-
surement of amino acid concentrations were taken at
the same time as mucosa biopsies. The minimum dis-
tance between biopsy sites was 2 cm. The average
biopsy size was 10 mg wet weight. All biopsies were
taken from a portion of the colon that was located in
the abdominal wall. No patient was included with any
signs of mucosa swelling, edema, necrosis, bleeding, or
malfunction. If mucosal function was unclear, we used
laser Doppler flowmetry10 to confirm the normality of
mucosal flow patterns.
Procedures
Study methods and data analysis were discussed in
detail previously.9 The free and protein-bound amino
acids in tissue biopsies were separated by protein pre-
cipitation. After protein hydrolysis, amino acids were
separated from the accompanying impurities by cation-
exchange chromatography. For capillary gas chroma-
tography and combustion isotope ratio mass spectrom-
etry analysis, amino acids from proteins (on average
7–8 ng) were then converted to the N-acetyl n-propyl
ester. For gas chromatography and quadrupole mass
spectrometry analysis, we prepared the tert-butyldi-
methylsilyl derivative from free intracellular amino
acids. N-acetyl n-propyl-amino acid derivatives were
analyzed in a capillary gas chromatography and com-
bustion isotope ratio mass spectrometry system that
consisted of a Hewlett-Packard 5890 Series II gas chro-
matograph (Hewlett-Packard) interfaced to a mass
spectrometer Delta S (Finnigan MAT, Bremen, Ger-
many). Tert-butyldimethylsilyl derivatives were ana-
lyzed by a gas chromatography and quadrupole mass
spectrometry system (MSD 5971D, Hewlett-Packard).
Isotopomere ratios of the sample were obtained by
electron impact ionization and selected ion monitoring
at mass-to-charge ratios 303 and 302. Data were
expressed as tracer:tracee ratios.
Plasma amino acid levels were measured by an auto-
analyzer (Beckman Instruments, Fulton, CA).
Calculations
The tissue fractional synthetic rate in the metabolic
steady state was calculated by dividing the increment
in protein-bound 1-[13C]-leucine tracer:tracee ratio by
enrichment of the precursor pool.9 As a substitute for
the true precursor pool enrichment (tRNA-bound
amino acid enrichment), we used the free homogenate
1-[13C]-leucine tracer:tracee ratio.11 Increments of pro-
tein-bound 1-[13C]-leucine enrichment between biopsy
samples were calculated from isotope ratios [13C]/[12C]
using a correction factor that takes into account dilu-
tion of the label at the carboxyl position by the other
carbon atoms in the derivatized leucine.9 The frac-
tional synthetic rate (FSR) was then calculated as fol-
lows:
FSR 





 60  100 (%/h)
RL(ti) and RL (ti1) correspond to the tracer:tracee
ratio of colon protein-bound leucine in 2 subsequent
samples (i and i  1), separated by the time interval t
(min). RL‘(ti) and RL‘(ti1) indicate the tracer:tracee
ratios of colon free leucine in 2 subsequent samples.
Average values between RL‘(ti) and RL‘(ti1) were used
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as precursor enrichments for colon protein synthesis.
The factors 60 (min) and 100 are needed to express the
fractional synthetic rate in percentage per hour.
To analyze the speed of tracer incorporation sepa-
rately in periods I and II, we calculated the absolute
increase of the protein-bound tracer:tracee ratio (in
percentage) per hour during the 10-hour isotope infu-
sion by the formulas
Period I:  RLI (%/h)  [{RL(t2)  RL(t1)}/t]  60
Period II:  RLII (%/h)  [{RL(t3)  RL(t2)}//t]  60
The relative change in the speed of tracer incorpora-
tion between periods I and II was calculated as
[( RLII RLI)/ RLI]  100
Statistics
Data are expressed as mean  SEM. Protein syn-
thetic rates, speed of tracer incorporation and amino
acid concentrations in control subjects and in subjects
receiving the amino acid infusion were compared by
the paired and unpaired Student’s t test. A p value of
.05 or less was taken as indicating a significant differ-
ence.
RESULTS
Plasma total amino acid concentration rose signifi-
cantly during amino acid infusion (end of period II:
4036  91 mol/L, p  .05 vs 2679  88 mol/L at the
end of period I), whereas total amino acid concentra-
tion remained unchanged in control patients (end of
period II: 2838  77 mol/L, n.s. vs 2804  92 mol/L
at the end of period I) resulting in a significant differ-
ence of amino acid concentrations between controls and
subjects receiving amino acids at the end of period II
(p  .05).
Table I presents the tracer:tracee ratios in the
mucosa free homogenate leucine pool ( precursor pool
for protein synthesis) in the 2 study groups. The values
of protein-bound leucine enrichment at the different
sampling points are presented in Table II. In control
patients, tracer incorporation into mucosa protein was
almost linear. The slopes ( speed of tracer incorpora-
tion  rise in tracer:tracee enrichment/hour) were
identical throughout the study. Thus, tracer:tracee
ratios (%) in colon mucosal protein rose by 0.069 
0.014 per h in period I and by 0.069  0.006 per h in
period II. In contrast, the speed of tracer incorporation
fell significantly when amino acids were given instead
of saline in period II. In the amino acid group, tracer:
tracee ratios in colon mucosal protein rose by 0.079 
0.008 per hour in period I and only by 0.058  0.007
per hour in period II (p  .05). The relative change of
the slopes between periods I and II in the 2 groups
differed significantly between groups (control: 22.2% 
29.0%; amino acid infusion: 25.6%  7.9%, p  .05).
After amino acid infusion, we observed a significant
decrease in the fractional synthetic rate of colon
mucosa (0.95%  0.13%/hour at the end of period II,
p  .05 vs 1.34  0.10 at the end of period I). In
contrast, the fractional synthetic rate of colon mucosa
remained unchanged throughout the study in control
patients (1.00%  0.17%/hour at the end of period I,
not significant vs 1.03  0.05 at the end of period II).
Thus, the percent change of colon protein synthesis
between periods I and II differed significantly between
patients receiving amino acids and control patients
(Fig. 1).
DISCUSSION
In control patients, colon protein synthetic rate and
the speed of tracer incorporation remained stable dur-
ing the 10-hour isotope infusion. These findings are in
contrast to our previous observations in ileum mucosa
of comparable postoperative patients. In postsurgical
ileum mucosa of the latter patients, protein synthesis
declined rapidly, falling significantly from about
1.11%/hour in period I to 0.39%/hour in period II.11
It had been argued that this decline is artificial
because of rapid mucosal tracer losses due to enzyme
secretion, cell exfoliation, or protein degradation,
thereby questioning the validity of the continuous
tracer infusion technique for measuring protein syn-
thesis in intestinal mucosa.12,13 However, such a mech-
TABLE I
Tracer:tracee ratios of 1-[13C]-leucine in free intracellular leucine of
colon mucosa*
Sample 1 Sample 2 Sample 3
Control 6.67  0.50 6.43  0.59 7.14  0.59
Amino acid 6.55  0.33 6.00  0.45 6.56  0.35
*Values are given as % (mean  SEM). Sample 1 was taken after 180
min, sample 2 after 360 min, and sample 3 after 600 min of isotope
infusion. Patients in the amino acid group received 67 mg/kg h of
amino acids between 360 and 600 min. Control patients continued to
fast throughout the study.
TABLE II
Tracer:tracee ratios of 1-[13C]-leucine in colon mucosa protein*
Sample 1 Sample 2 Sample 3
Amino acid 1 0.13 0.35 0.63
2 0.12 0.45 0.50
3 0.22 0.45 0.76
4 0.28 0.37 0.43
5 0.28 0.47 0.66
6 0.22 0.41 0.66
7 0.32 0.61 0.85
8 0.17 0.41 0.67
9 0.11 0.36 0.71
10 0.43 0.60 0.73
11 0.30 0.53 0.82
12 0.17 0.60 0.95
Control 1 0.16 0.50 0.78
2 0.13 0.42 0.77
3 0.12 0.29 0.49
4 0.11 0.19 0.43
5 0.19 0.35 0.66
*Values are given as percentage. Sample 1 was taken after 180 min,
sample 2 after 360 min, and sample 3 after 600 min of isotope
infusion. Patients in the amino acid group received 67 mg/kg h of
amino acids between 360 and 600 min. Control patients continued to
fast throughout the study.
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anism would require selective loss of labeled protein or
tracer. Considering the basic principles of tracer tech-
niques, such a scenario is highly unlikely because the
normal assumption is random kinetics, which leads to
proportionate losses of labeled and unlabeled protein
molecules no matter by which mechanism. Anything
else would require a selective isotope effect that is
absent in humans.14
In the past, a similar problem had been identified at
the liver when protein synthesis was also examined via
continuous tracer infusion.15–17 This seeming decline
of protein synthesis over time in some tissues can be
explained by the existence of different protein pools
with different protein turnover rates and correspond-
ingly different speeds of isotope incorporation.15,17
Thus in a mixed sample, enrichments of all pools will
contribute to the measured total enrichment. After a
certain amount of time, isotopic enrichment in each
pool will reach a plateau that corresponds to the pre-
cursor pool enrichment. However, in a rapid-turnover
protein pool, the maximum (plateau) enrichment may
already be reached during tracer infusion. Subse-
quently, if the precursor pool enrichment remains con-
stant, isotopic enrichments in this protein pool will not
change anymore. Thereby, this pool will no longer con-
tribute adequately to the increasing enrichment found
in mixed samples taken at a later time. After an isoto-
pic plateau has been reached in the rapid-turnover
protein pool, only enrichments of proteins in the slow-
turnover pool will continue to rise. Therefore, corre-
sponding mixed enrichments will be lower than before
because the enrichment rise in the rapid-turnover pro-
tein pool is now absent. This mechanism will result in
a seeming deceleration of tracer incorporation and fall
of protein synthesis during this time. Furthermore,
effects of any metabolic manipulation performed after
this point will remain undetectable in this rapid-turn-
over pool.
According to animal data, this rapidly turning over
protein pool in the gut mainly consists of enzymes or
epithelial glycoproteins such as lactosaminoglycans or
proteoglycans, which were found to have turnover
rates in the range of 20%–30%/hour, depending on the
physiologic conditions.18–22 Nevertheless, because the
size of this specific pool amounts to 10% of the total
protein pool,23–25 the vast majority of proteins can still
be studied in tracer infusion experiments such as ours.
Interestingly, the contribution of this rapid-turnover
pool to total mucosal protein synthesis seems to vary in
the intestinal tract. Our finding of a constant tracer
incorporation in colon but not in ileum mucosa sug-
gests proteins with such a high turnover rate to be less
common in the large bowel. There are several experi-
mental findings supporting this qualitative difference
between ileum and colon protein synthesis. In humans,
the percentage of proliferating cells is significantly
lower in colon than in ileum mucosa (10.3% vs
17.8%).26 Furthermore, glycoprotein production differs
significantly between colon and ileum.27 These differ-
ences are relevant when mucosal protein synthesis is
determined by the flooding dose technique. Although
there are various disadvantages in comparison to con-
tinuous isotope infusion, the flooding dose technique is
specifically suited to examine protein synthetic rates in
rapidly turning over proteins.13 When protein synthe-
sis is evaluated up to 10 minutes after tracer applica-
tion, rat colon demonstrates a fractional synthetic rate
of 62.1%/d, which is significantly lower than the corre-
sponding rate in ileum (103.4%/d).28
Another key finding of our study is that we found a
decrease in colon protein synthesis during infusion of
standard amino acid solutions. This decline occurred
despite an amino acid infusion rate that corresponded
to recent clinical recommendations for patients in sur-
gical stress and that was shown to optimally conserve
total body protein.1
In the past, several studies elucidated the fate and
metabolic effects of IV amino acids in healthy and
diseased men. It is generally accepted that, compared
with the fasting state, IV amino acids stimulate total
body protein synthesis.2 One portion of this stimula-
tion takes place in skeletal muscle tissue where even a
short-term amino acid infusion may double protein
synthesis in situ.29 However, the majority of peripher-
ally administered amino acids are being removed in
the splanchnic bed.6,7 There is also evidence from
human studies that infused amino acids predomi-
nantly stimulate splanchnic protein synthesis.5 Pre-
sumably, a large portion of this accelerated protein
synthesis can be attributed to hepatic albumin synthe-
sis because the latter rises when amino acid supply is
increased.30,31
The fate of the infused amino acids in different com-
partments of the human splanchnic region such as in
the gut and their relative contribution to total splanch-
nic protein turnover are still unclear. Because of sig-
nificant technical and methodological limitations, pre-
cise human studies are still lacking. There is, however,
strong evidence from selective intestinal arteriovenous
balance measurements in dogs that gut amino acid
uses rise, irrespective whether proteins are adminis-
tered enterally32 or, as amino acids, parenterally.33,34
However, this use does not necessarily reflect en-
hanced protein synthesis because decreased protein
FIG. 1. Effect of an amino acid infusion on protein fractional synthetic
rate in colon mucosa. Values are given as mean  SEM and repre-
sent percent changes between periods I and II. After a baseline
period of 3 hours (period I), patients in the amino acid group received
67 mg/kg h of amino acids over 4 hours (period II), whereas control
subjects (saline infusion) remained in a fasting state during the
corresponding time. §p  .05 vs control.
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breakdown or accelerated amino acid oxidation is pos-
sible.
With respect to protein synthesis, enteral protein
feeding was without relevant effect in the jejunum of
adult pigs,35–37 or in the duodenum of adult man.38 In
contrast to whole proteins, enteral application of free
amino acids seems to be more effective, although large
amounts may be required. After a short-term applica-
tion (1.25 hours) of only small amounts (0.38 g/kg), gut
protein synthesis did not rise in young pigs,36 whereas
significantly more enteral amino acids (	1 g/kg)
increased small-bowel protein synthesis in dogs39 and
duodenal protein synthesis in man.40 Such an enteral
dose/effect relationship may also exist for specific
amino acids such as glutamine, which, when given
orally at a rate of 20 mg/kg per h, did not alter human
enterocyte proliferation or duodenal protein synthe-
sis.41,42 Only large enteral amounts (	100 mg/kg per
h) were found to stimulate protein synthesis in canine
and human intestinal mucosa.40,43
Parenteral effects of amino acids on protein synthe-
sis are less clear and may depend on technique, site, or
species. Thus, amino acid infusion increased intestinal
protein synthesis in dogs44 but not in pigs36,45 or
human duodenum.46 Considering our rigid study
design (triple mucosal biopsies in the same subjects
before and during amino acid infusion), our findings
strongly support the idea that a potential anabolic
effect of an increased basolateral amino acid supply at
the gut does not imply a rise in intestinal protein
synthesis. If these actions indeed exist also in man,
they are more likely to be mediated by a reduction of
protein breakdown. However, it cannot be excluded
that potential metabolic effects also depend on the
clinical condition of the subjects.
In fact, it was surprising to observe an actual fall of
gut protein synthesis during amino acid infusion. Such
an observation has not been made before in any exper-
imental setting, which, however, has never included
conditions of postsurgical stress and the additional
supplementation of glutamine. Considering these spe-
cific circumstances of our patients and potential non-
nutrition effects of glutamine, a hypothesis might be
generated to explain the observed inhibitory effects of
amino acids on large-bowel protein synthesis. Besides
being an important substrate for mucosal energy
metabolism, glutamine also has a variety of other
actions that may eventually gain relevance during
postoperative stress. However, it should be noted that
such a hypothesis is mostly based on experimental
data from animal or in vitro studies.
Explanation of a putative glutamine effect requires a
closer examination of the mechanisms involved in sur-
gical injury at the intestinal tract. Surgical trauma and
the associated inadequate luminal nutrition may cause
profound alterations of mucosal morphology and func-
tion, including reduced abundance of digestive en-
zymes, diminished tight-junction integrity, or en-
hanced enterocyte damage and apoptosis.47,48 The lat-
ter changes stimulate a mucosal proinflammatory
response, with recruitment of inflammatory cells into
the intestinal wall,49–51 local release of proinflamma-
tory mediators,52,53 and subsequent compensatory
stimulation of enterocyte protein synthesis and prolif-
eration to account for the accelerated loss of entero-
cytes.54,55
Glutamine may have counteracted these inflamma-
tory reactions and mucosal damage due to its protec-
tive antiinflammatory effects.56,57 These effects include
increased intracellular glutathione availability, there-
by inhibiting NF
B activation and ultimately produc-
tion of proinflammatory mediators.58 These mecha-
nisms have also been described in the gut,59–62 where
they lowered cytokine release from mucosal tissues
and mesenteric mononuclear cells and reduced entero-
cyte apoptosis.63–66 The attenuated inflammatory
response and enhanced enterocyte lifespan will also
attenuate the signals and the need for a compensatory
acceleration of enterocyte proliferation. The glu-
tamine-related reduction of mucosal damage and
inhibitory effects on inflammatory reactions might
then explain the acute fall in the accelerated colon
protein synthesis during amino acid supplementation.
That such immunomodulatory mechanisms of glu-
tamine might be also effective at the human gut is
suggested by a study of Van der Hulst et al,67 who
found parenteral glutamine supply to decrease the
number of intraepithelial lymphocytes.
From our data, it is not possible to decide whether
glutamine-containing amino acid solutions are clini-
cally beneficial or detrimental. However, in the past,
various experimental studies in different models of
mucosal injury demonstrated glutamine supplementa-
tion to improve mucosal healing (eg, Wischmeyer et
al,56 Ersin et al57). Our data would be compatible with
such a hypothesis.
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